Merck & Co Inc
Merck’s 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
Sopa Images | Lightrocket | Getty Images Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street’s expectations, as the company temporarily paused shipments of a key vaccine into China. The pharmaceutical giant anticipates 2025 sales of $64.1 billion to $65.6 billion, lower than the $67.31 billion that analysts surveyed by […]
Read More
Stock futures jump after Trump pauses Canada tariffs: Live updates
Traders work on the floor of the New York Stock Exchange during morning trading on February 03, 2025 in New York City. Michael M. Santiago | Getty Images Stock futures rose Monday night after U.S. President Donald Trump paused planned tariffs on goods from Canada, just hours after a reprieve was also announced on planned […]
Read More
5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day: 1. Trade tailspin 2. Tariff tremor U.S. President Donald Trump speaks with members of the media as he departs the White House, in Washington, U.S., Jan. 31, 2025. Carlos Barria | Reuters Trump slapped 25% tariffs on goods from Canada […]
Read More
Reid Hoffman enters ‘wondrous and terrifying’ world of health care with latest AI startup
Reid Hoffman, Partner at Greylock and co-founder LinkedIn, speaks during the WSJ Tech Live conference hosted by the Wall Street Journal at the Montage Laguna Beach in Laguna Beach, California, on October 21, 2024. Frederic J. Brown | Afp | Getty Images LinkedIn co-founder and venture capitalist Reid Hoffman became a billionaire from his business […]
Read More
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November 20, 2020. Carlos Barria | Reuters Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on […]
Read More
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon from San Francisco! This week, Ashley and I are attending the annual JPMorgan Health Care Conference – the largest gathering of biotech and pharma execs, […]
Read More
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, August 29, 2020. Andrew Kelly | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The U.S. Food and […]
Read More
These innovative biotech stocks have a good chance of breaking out in 2025
Trends may be shifting in favor of biotech stocks in 2025 after several years of poor performance, but it would still be wise to place your bets carefully on some of the most innovative names. “We’re still optimistic on the outlook for biotech,” said Stacey Sears, senior vice president and portfolio manager at Emerald Advisors, […]
Read More
Stocks making the biggest moves premarket: General Mills, Nvidia, Jabil and more
Check out the companies making headlines before the bell. General Mills — The maker of consumer food products such as Cheerios and Cocoa Puffs sank 5% after trimming its outlook for 2025. General Mills said it now expects adjusted earnings per share to fall between 3% and 1%. The company previously expected that figure to […]
Read More
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. The oral drug has not yet […]
Read More